M.A.C.

M.A.C. sells colour cosmetics at accessible prestige prices — most lipsticks sit in the low-to-mid twenties — through a mix of its own stores, department store counters, Sephora and Ulta, and its own site. The gross margins are a beauty brand's, and the volumes are enormous. But the model's distinguishing feature was never price or product. It was who stood behind the counter.

Frank Toskan, a makeup artist and photographer, and Frank Angelo, who ran hair salons, started M.A.C. in 1984 because studio lighting made existing cosmetics look wrong on film. The products were built for professionals: high pigment, matte finishes, shade ranges that covered skin tones the industry had ignored. The distribution strategy followed from that. M.A.C. seeded product to working makeup artists, staffed its counters with practising artists rather than commissioned salespeople, and ran a professional discount programme that turned every artist in a city into a distribution node. Backstage credibility flowed outward to consumers, not the other way around. Madonna's 1990 Blond Ambition tour did more for the brand than any campaign could have bought, because the artist doing her face used M.A.C. and said so.

Estée Lauder bought 51% in 1994 and the rest in 1998, and did what a conglomerate does well: took a brand with roughly a hundred doors and put it in dozens of countries. What it did not do — and this is the comparison with NARS worth holding onto — is keep the founders. Toskan left after Lauder took full control; Angelo had died in 1997. NARS sold its equity and kept its author. M.A.C. sold both.

M.A.C.'s moat was built on three things, and the state of each explains the current position.

The first was professional credibility — artists used it, so consumers wanted it. That asset was genuine and largely non-replicable in 1994. It is much less scarce in 2026, because every professional makeup artist now has an Instagram account and can either endorse anyone or launch their own line. Pat McGrath did exactly that.

The second was shade range. M.A.C. carried foundations for deep skin tones for decades before the industry accepted this was a commercial necessity rather than a courtesy. That was a real competitive advantage and it was comprehensively neutralised in 2017, when Fenty Beauty launched with forty shades and made inclusive ranges table stakes overnight. A moat that becomes an industry standard stops being a moat.

The third — and the one that is still intact — is VIVA GLAM. Since 1994 M.A.C. has given 100% of the selling price of a specific lipstick to HIV/AIDS causes, raising more than $500 million. This is worth distinguishing carefully from cause marketing. Most cause-linked campaigns donate a percentage of profit, cap the total, and spend more publicising the donation than donating. M.A.C. underwrites the cost of goods and gives away the entire price, has done so for over thirty years, and started in 1994 when a mainstream cosmetics company associating itself with AIDS was a commercial risk rather than a reputational asset. That is cause-as-strategy in the only version that works: expensive, sustained, and adopted before it was safe.

The verdict is eroding rather than narrow because the trajectory is visible in the parent's own filings. Estée Lauder's fiscal 2025 makeup net sales fell 6%, and the company attributed the decline primarily to M.A.C.

The founders' allocation decisions were extraordinary and mostly non-financial. Toskan and Angelo spent money on artists rather than advertising, and gave away an entire product line's revenue starting in 1994, at a moment when a cosmetics company publicly attaching itself to AIDS was a commercial gamble and not a marketing opportunity. VIVA GLAM has since raised more than $500 million. The reason it reads as authentic thirty years later is precisely that it was not safe when it started — cause-washing is identifiable by its timing, and M.A.C. was early.

Estée Lauder's allocation record with the brand is the harder judgement. Buying 51% in 1994 and the balance in 1998 for a reported $60 million ranks among the best acquisitions in consumer goods history by any multiple you care to apply. The scaling was executed well. But over the following two decades M.A.C. was managed increasingly as a volume engine — high collaboration cadence, aggressive door expansion, a promotional rhythm that trained customers to wait — while the assets that made it distinctive, artist staffing and professional credibility, faced constant margin pressure. Fenty in 2017 exposed the result: M.A.C.'s inclusivity advantage had been a genuine competitive position for two decades, and the brand did not defend it when someone else claimed the ground.

Set the two conglomerate outcomes side by side. Shiseido bought NARS's equity and left its author in place, and the brand still looks like itself. Estée Lauder bought M.A.C.'s equity and its authorship, and thirty years later the brand looks like whatever the current volume plan requires.